Jim Simons Arrowhead Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $5.5 Million - $8.05 Million	-259,500 Reduced 68.02%	122,000 $3.73 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $89,080 - $122,672	-3,400 Reduced 0.88%	381,500 $10.3 Million
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $2.32 Million - $3.81 Million	92,100 Added 31.45%	384,900 $13.7 Million
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $4.76 Million - $7.74 Million	-201,000 Reduced 40.7%	292,800 $7.44 Million
Q4 2022 Feb 13, 2023	SELL	$28.0 - $40.56 $7.32 Million - $10.6 Million	-261,600 Reduced 34.63%	493,800 $20 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $9.32 Million - $15.2 Million	314,400 Added 71.29%	755,400 $25 Million
Q2 2022 Aug 12, 2022	BUY	$27.79 - $50.61 $1.69 Million - $3.07 Million	60,700 Added 15.96%	441,000 $15.5 Million
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $15.1 Million - $26.6 Million	380,300 New	380,300 $17.5 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $3.14 Million - $4.46 Million	-54,100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $7.3 Million - $10.6 Million	-125,100 Reduced 69.81%	54,100 $3.38 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $3.88 Million - $5.64 Million	-62,400 Reduced 25.83%	179,200 $14.8 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $14.8 Million - $21.9 Million	241,600 New	241,600 $16 Million
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $17.4 Million - $28.8 Million	-666,400 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $1.15 Million - $3.53 Million	-55,900 Reduced 7.74%	666,400 $19.2 Million
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $1.82 Million - $4.72 Million	64,700 Added 9.84%	722,300 $45.8 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $3.45 Million - $4.57 Million	-131,200 Reduced 16.63%	657,600 $18.5 Million
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $10.8 Million - $17.8 Million	618,400 Added 362.91%	788,800 $20.9 Million
Q1 2019 May 14, 2019	BUY	$12.05 - $20.18 $2.05 Million - $3.44 Million	170,400 New	170,400 $3.13 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account